Medical Services related to Paul Michael Grossman MD

Frequently Asked Questions About PAD

Frequently Asked Questions about peripheral arterial disease or PAD (sometimes called peripheral vascular disease) and how the University of Michigan Cardiovascular Center's Peripheral Arterial Disease Clinic can help.

PAD Treatments

Treatments for peripheral artery disease or PAD (sometimes called peripheral vascular disease) include both surgical and non-surgical options. All PAD patients are treated using risk factor management and exercise. Surgery is reserved for patients with the most serious symptoms.

Peripheral Arterial Disease (PAD)

The difference between peripheral artery disease or PAD (sometimes called peripheral vascular disease) and heart disease is that the blockages are outside your heart, usually in the legs. The University of Michigan’s Peripheral Arterial Disease Program brings together a multidisciplinary team of physicians to create a treatment plan tailored to your needs.

TAVR: Transcatheter Aortic Valve Replacement

TAVR stands for Transcatheter Aortic Valve Replacement, a minimally invasive, catheter-based procedure to replace the diseased aortic valve in patients with severe aortic stenosis. Aortic stenosis is a condition in which the aortic valve does not open fully due to a thickening of the valve leaflets, often caused by a buildup of calcium on the leaflets. This thickening makes it difficult for the leaflets to open and close, which decreases blood flow from the heart to the body. The condition may cause the heart to work harder to pump blood. For decades, open heart surgical aortic valve replacement (SAVR) has been the standard treatment for severe aortic stenosis, but in the past few years TAVR has rapidly replaced SAVR in high-risk patients as well as patients at moderate risk for surgery. This is due to excellent clinical trial results showing equal or better patient outcomes compared to SAVR. Most recently, in August of 2019, TAVR was approved for patients at low risk for surgery. These low-risk patients, whose aortic stenosis would typically receive an open-heart surgical aortic valve replacement, can now be considered a candidate for a TAVR procedure.